The reference case ten years later: Has comparing cost-effectiveness analyses improved?

Clinical Therapeutics

Volumn 28, Issue 8, 2006, Pages 1182-1183

  Lyles, Alan ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DECISION MAKING; EDITORIAL; HEALTH CARE COST; LABORATORY TEST; MARKETING; MORBIDITY; STANDARDIZATION;

COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; HUMANS;

EID: 33748535486     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2006.08.009     Document Type: Editorial

References (5)

1. In: Gold M.R., Siegel J.E., Russell L.B., and Weinstein M.C. (Eds). Cost-Effectiveness in Health and Medicine (1996), Oxford University Press, New York, NY
2. Angus D.C., Clermont G., Watson R.S., et al. Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. Pediatrics 112 (2003) 1351-1360
3. Fuhlbrigge A.L., Bae S.J., Weiss S.T., et al. Cost-effectiveness of inhaled steroids in asthma: Impact of effect on bone mineral density. J Allerg Clin Immunol 117 (2006) 359-366
4. De Angelis C.D., Drazen J.M., Frizelle F.A., et al., International Committee of Medical Journal Editors. Clinical trial registration: A statement from the International Committee of Medical Journal Editors. N Engl J Med 351 (2004) 1250-1251
5. De Angelis C.D., Drazen J.M., Frizelle F.A., et al., International Committee of Medical Journal Editors. Is this clinical trial fully registered?-a statement from the International Committee of Medical Journal Editors. N Engl J Med 352 (2005) 2436-2438